In human breast cancer (BC), both intratumoral and stromal TIL have been consistently and significantly associated with overall survival (OS) in the HER2+ and triple-negative subgroups (Dieci et al., 2015; Hendry et al., 2017). This evidence concerns the gene ERBB2 and breast cancer.